
LITTLE ELM, Texas -- (Business Wire)
Retractable Technologies, Inc. (NYSE AMEX: RVP) announced today that its
Board of Directors has declared dividends to holders of Series I Class B
and Series II Class B Convertible Preferred Stock in the amounts of
$72,000 and $219,700, respectively. The dividend amount is $0.50 per
share for Series I Class B shareholders and $1.00 per share for Series
II Class B shareholders. Dividends have accrued at 10% per annum and
cover amounts in arrears from June 30, 2010 through date of conversion
or June 30, 2011, whichever is applicable. The dividends will be paid on
July 15, 2011 to shareholders of record as of the close of business on
July 8, 2011.
Retractable manufactures and markets safety medical products,
principally VanishPoint® automated retraction safety
syringes, automated retraction blood collection devices, and automated
retraction IV catheters, that virtually eliminate healthcare worker
exposure to accidental needlestick injuries. These revolutionary devices
use patented technology that causes the contaminated needle to retract
automatically, a feature that is designed to prevent both accidental
needlestick injury and device reuse. Retractable also manufactures and
markets Patient Safe® syringes that are uniquely designed to
reduce the risk of bloodstream infections resulting from catheter hub
contamination. Retractable's products are distributed by various
specialty and general line distributors. For more information on
Retractable, visit our website at www.vanishpoint.com.
Forward-looking statements in this press release are made pursuant to
the safe harbor provision of the Private Securities Litigation Reform
Act of 1995 and reflect our current views with respect to future events.
We believe that the expectations reflected in such forward-looking
statements are accurate. However, we cannot assure you that such
expectations will materialize. Our actual future performance could
differ materially from such statements.
Factors that could cause or contribute to such differences include, but
are not limited to: our ability to maintain liquidity; our maintenance
of patent protection; the impact of current litigation; our ability to
maintain favorable supplier arrangements and relationships; our ability
to quickly increase capacity in response to an increase in demand; our
ability to access the market; our ability to maintain or lower
production costs; our ability to continue to finance research and
development as well as operations and expansion of production; the
increased interest of larger market players, specifically Becton
Dickinson and Company, in providing devices to the safety market; and
other risks and uncertainties that are detailed from time to time in
Retractable's periodic reports filed with the U.S. Securities and
Exchange Commission.

Contacts:
Retractable Technologies, Inc.
Investor Contact:
Douglas
W. Cowan, 888-806-2626 or 972-294-1010
Vice President and Chief
Financial Officer
Source: Retractable Technologies, Inc.
© 2026 Canjex Publishing Ltd. All rights reserved.